Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Gerhardt Attard
Based on 99 articles published since 2008
||||
Expertise Level
The expertise of Gerhardt Attard ranks in the
  • Top 0.027%
  • ... of 129,687 published authors worldwide on Prostatic Neoplasms
  • ... from 2008 through 2018
  • ... based on contributions to 99 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Attard, G   ·   Attard, Gerhardt
Work Locations
Details
Most likely:    University of London      
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Research Data Management and Statistics Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, Hospital Ramón y Cajal, Madrid. · Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Integrative Biology, University of Trento, Trento, Italy. · Oncology Unit, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona. · Department of Medical Oncology, H. Universitario Lucus Augusti, Lugo. · Department of Medical Oncology, H.U. Son Espases Mallorca, Mallorca. · Department of Medical Oncology, IDIBAPS Hospital Clinic, Barcelona. · Department of Medical Oncology, Hospital de Orense, Orense. · Department of Medical Oncology, Hospital Universitario Reina Sofía, Córdoba. · Department of Medical Oncology, Instituto Valenciano de Oncología Valencia, Valencia. · Department of Medical Oncology, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla. · Department of Medical Oncology, H.U. Parc Taulí, Sabadell, Barcelona. · Department of Medical Oncology, Hospital de León, León. · Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza. · Department of Medical Oncology, Hospital Regional y Hospital Virgen de la Victoria, Malaga. · Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain. · Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. · Institute for Precision Medicine, Weill Cornell Medicine, New York, USA. · Department of Medical Oncology, Universidad Católica San Antonio de Murcia-UCAM, Murcia, Spain. · Pubmed 28472366
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Translational Cancer Therapeutics Laboratory, UCL Cancer Institute, London, UK. · Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK. · Bill Lyons Informatics Centre, UCL Cancer Institute, London, UK. · Division of Cancer Studies, King's College London, London, UK. · Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK. · Division of Surgery and Interventional Science, University College London, London, UK. · Cancer Immunology Unit, UCL Cancer Institute, London, UK. · Research Department of Haematology, UCL Cancer Institute, London, UK. · Department of Histopathology, University College London Hospitals NHS Foundation Trust, London, UK. · Definiens AG, Munich, Germany. · Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK. · Cancer Genomics Laboratory, The Francis Crick Institute, London, UK. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK. · The Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London, UK. · Department of Urology, UCLH NHS Foundation Trust, London, UK. · Centre for Medical Imaging, Universtiy College London, London, UK. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Department of Medical Oncology, Royal Marsden Hospital, London, UK. · Centre for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark. · Computational Health Informatics Program (CHIP), Harvard Medical School, Boston, USA. · MTA-SE-NAP Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary. · Division of Surgery, Department of Surgery and Cancer, Imperial College London, UK. · Department of Urology, Imperial College Healthcare NHS Trust, London, UK. · Pubmed 28961847
  • Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · The Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Epic Sciences, San Diego, CA, USA. · Department Urology, University of Michigan Medical School, Ann Arbor, MI, USA. · Comprehensive Cancer Center, Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Pubmed 27539393
2016
  • Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London The Royal Marsden NHS Foundation Trust, London, UK. · Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London The Royal Marsden NHS Foundation Trust, London, UK · Pubmed 27091809
  • Centre of Evolution and Cancer, The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK; and at The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, 1650 Orleans Street, CRB1-1M45, Baltimore, Maryland 21231, USA. · Pubmed 27804988
  • Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Clinical Academic Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK; Oncogenetics Team, Division of Cancer Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Erasmus University Medical Center, Rotterdam, Netherlands. · Departments of Pathology Urology, Comprehensive Cancer Center and Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Johns Hopkins Hospital, Baltimore, MA, USA. · Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 26074382
  • Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Astex Pharmaceuticals, Cambridge, United Kingdom. · Department of Medicine, University of Washington School of Medicine and GRECC at VAPSHCS Seattle, Washington. Department of Urology, University of Washington School of Medicine and GRECC at VAPSHCS Seattle, Washington. · Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 27197266
  • Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · University of Florence, Florence, Italy. · Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · The Institute of Cancer Research and The Royal Marsden, London, UK. · Pubmed 27191887
  • Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds. · Department of Urology, University Hospital, Bern, Switzerland. · Patient rep, MRC Clinical Trials Unit at UCL, London, UK. · Department of Oncology, Weston Park Hospital, Sheffield & Doncaster, UK. · Kent Oncology Centre, Maidstone Hospital, Maidstone, UK. · Department of Oncology, Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Department of Oncology, Poole Hospital NHS Foundation Trust and Royal Bournemouth Hospital NHS Foundation Trust, Chur, Switzerland. · Kantonsspital Graubünden, Chur, Switzerland. · Department of Oncology, Derby Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Oncology, Cheltenham General Hospital & Hereford County Hospital, UK. · Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Oncology and Haematology Clinical Trials Unit, Queen Alexandra Hospital, Portsmouth, UK. · Department of Oncology, Queen's Hospital, Romford, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Department of Urology, Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Group, Mount Vernon Hospital, Middlesex, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, East Sussex Hospitals Trust, East Sussex, UK. · Department of Oncology, Western General Hospital, Edinburgh, UK. · Centre for Cancer Research and Cell Biology, Queens University Belfast/Belfast City Hospital, Belfast, UK. · Department of Oncology, East Lancashire Hospitals NHS Trust, East Lancashire, UK. · Department of Oncology & Radiotherapy, South Tees NHS Trust, Middlesbrough, UK. · Department of Oncology, Churchill Hospital, Oxford, UK. · Department of Oncology, Sussex Cancer Centre, Brighton, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Royal Devon & Exeter Hospital, Exeter, UK/Torbay Hospital, Torquay, UK. · Department of Oncology, Nottingham University Hospitals NHS trust, Nottingham, UK. · Department of Oncology & Radiotherapy, Clatterbridge Cancer Centre, Wirral, UK. · Department of Oncology, Southend & Basildon Hospitals, Essex, UK. · The South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK. · Pubmed 26719232
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom. · Medical Research Council Clinical Trials Unit, University College, London, United Kingdom. · Department of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Velindre Hospital, Cardiff, United Kingdom. · Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. · Royal Preston Hospital, Preston, United Kingdom. · Cantonal Hospital St Gallen, St Gallen, Switzerland. · Greater Manchester Group, Manchester, United Kingdom. · Leeds Beckett University, Leeds, United Kingdom. · Belfast City Hospital, Belfast, United Kingdom. · Singleton Hospital, Swansea, United Kingdom. · Royal Shrewsbury Hospital, Shrewsbury, United Kingdom. · Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. · CCO Liverpool Warrington Aintree, Liverpool, United Kingdom. · Pubmed 26606329
2015
  • The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK · Division of Medicine, Weill Cornell Medical College, New York, USA. · Pubmed 25862438
  • Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 26065613
  • The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 26025264
  • Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. · Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 25251387
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. · The Institute of Cancer Research, London SW7 3RP, UK. Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medicine, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medicine, NY 10021, USA. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Pubmed 26537258
  • Genentech Inc., South San Francisco, CA, USA. · The Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, Surrey, UK. · The Institute of Cancer Research, London, UK. · Epic Sciences Inc., San Diego, CA, USA. · Core Diagnostics, Palo Alto, CA, USA. · Pubmed 26379078
  • The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK. · Pubmed 26032550
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · The Institute of Cancer Research and the Royal Marsden, London, UK. · Pubmed 25897673
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK. · Department of Medical Cell BioPhysics, MIRA Institute, University of Twente, 7522ND, Enschede, The Netherlands. · 1] Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK [2] Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5NG, UK. · Pubmed 25719830
  • Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 25555314
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 25454616
2014
  • The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Medical Research Council Clinical Trials Unit at University College London, London, UK. Electronic address: · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · University of Bern, Bern, Switzerland. · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Department of Urology, University Hospital, Bern, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Patient representative, Stockton-on-Tees, UK. · Patient representative, Northampton, UK. · University of Warwick, Warwick, UK. · Pubmed 24985962
  • Prostate Targeted Therapy Group, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Division of Cancer Therapeutics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Pubmed 24840076
  • The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 24685433
  • The Institute of Cancer Research, London SM2 5NG, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medical College, New York, NY 10021, USA. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Pubmed 25232177
  • The Royal Marsden NHS Trust and The Institute of Cancer Research, Drug Development Unit, Downs Road, Sutton, Surrey SM2 5PT, UK. Electronic address: · Pubmed 24739898
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Guy's and St. Thomas' NHS Foundation Trust, Great Maze Pond, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 24074764
  • The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. · Guy's and St. Thomas NHS Foundation Trust, United Kingdom. · The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. Electronic address: · Pubmed 24433842
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK. · Academic Urology Unit, Sutton, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, UK. · Pubmed 24300975
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 24295792
2012
  • The Institute of Cancer Research, Sutton, Surrey SM2 5PT, UK. · Pubmed 22170708
2011
  • Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, United Kingdom. · Pubmed 21680542
  • Section of Medicine, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 21372223
2009
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 19509232
  • The Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK. · Pubmed 19962664
  • The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 19339269
2008
  • Institute of Cancer Research, Male Urological Cancer Research Centre, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK. · Pubmed 18594527
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom · and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
2016
  • From Weill Cornell Medicine, New York, NY, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY; The Institute of Cancer Research, London, United Kingdom, The Royal Marsden Hospital, London, United Kingdom. · Pubmed 27249694
2015
  • From the Institute of Cancer Research (J.M., S.C., S.S., S.M., H.M., R.P.-L., D.N.R., A.O., N.T., G.B., N.P., P.F., A.G., I.F., C.P., G.S., D.B., J.G., Z.Z., C.T.W., R.F., R.R., B.E., G.F., D. Roda, W.Y., R.B., H.P., R.A., A.S., R.E., G.A., C.J.L., A.A., E.H., J.S.B.), the Royal Marsden NHS Foundation Trust (J.M., S.S., R.P.-L., A.O., N.T., D.B., Z.Z., R.F., D. Roda, R.E., G.A., J.S.B.), and University College London Hospital (U.M.), London, Queen's University, Belfast (S.J.), University of Leeds, Leeds (C.R.), Churchill Hospital, Oxford (A.P.), University of Liverpool, Liverpool (S.H.), Beatson West of Scotland Cancer Centre, Glasgow (R.J.), and Christie Hospital, Manchester (T.E.) - all in the United Kingdom · the University of Michigan, Ann Arbor (D. Robinson, Y.-M.W., X.C., L.P.K., F.Y.F., A.M.C.) · Weill Cornell Medical College, New York (M.A.R.) · and Thomas Jefferson University, Philadelphia (K.E.K.). · Pubmed 26510020
  • Section of Medicine, The Institute of Cancer Research, London, UK. · Pubmed 25041380
2013
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 23470964
  • 1] Prostate Cancer Targeted Therapy Group and Drug Development Unit, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK [2] Memorial Sloan-Kettering Cancer Center (MSKCC) and Weill Cornell Medical College, Center for Prostate and Urologic Cancers, New York, NY, USA. · Pubmed 24169353
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23807167
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23928659
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, United Kingdom. · Pubmed 23565754
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23313031
2012
  • Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK. · Pubmed 22249187
  • Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom. · Pubmed 21986558
  • The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 22460813
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 22411952
2011
  • Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, UK. · Pubmed 21498309
2010
  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20159823
  • Drug Development Unit, Royal Marsden National Health Service Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19608618
  • Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Pubmed 20177423
2009
  • Institute of Cancer Research, Male Urological Cancer Research Centre, Sutton, Surrey, UK. · Pubmed 19040532
2008
  • Prostate Stem Cell Laboratory, Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 18398820
Probable:    Royal Marsden Hospital and Trust      
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Research Data Management and Statistics Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, Hospital Ramón y Cajal, Madrid. · Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Integrative Biology, University of Trento, Trento, Italy. · Oncology Unit, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona. · Department of Medical Oncology, H. Universitario Lucus Augusti, Lugo. · Department of Medical Oncology, H.U. Son Espases Mallorca, Mallorca. · Department of Medical Oncology, IDIBAPS Hospital Clinic, Barcelona. · Department of Medical Oncology, Hospital de Orense, Orense. · Department of Medical Oncology, Hospital Universitario Reina Sofía, Córdoba. · Department of Medical Oncology, Instituto Valenciano de Oncología Valencia, Valencia. · Department of Medical Oncology, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla. · Department of Medical Oncology, H.U. Parc Taulí, Sabadell, Barcelona. · Department of Medical Oncology, Hospital de León, León. · Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza. · Department of Medical Oncology, Hospital Regional y Hospital Virgen de la Victoria, Malaga. · Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain. · Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. · Institute for Precision Medicine, Weill Cornell Medicine, New York, USA. · Department of Medical Oncology, Universidad Católica San Antonio de Murcia-UCAM, Murcia, Spain. · Pubmed 28472366
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Translational Cancer Therapeutics Laboratory, UCL Cancer Institute, London, UK. · Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK. · Bill Lyons Informatics Centre, UCL Cancer Institute, London, UK. · Division of Cancer Studies, King's College London, London, UK. · Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK. · Division of Surgery and Interventional Science, University College London, London, UK. · Cancer Immunology Unit, UCL Cancer Institute, London, UK. · Research Department of Haematology, UCL Cancer Institute, London, UK. · Department of Histopathology, University College London Hospitals NHS Foundation Trust, London, UK. · Definiens AG, Munich, Germany. · Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK. · Cancer Genomics Laboratory, The Francis Crick Institute, London, UK. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK. · The Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London, UK. · Department of Urology, UCLH NHS Foundation Trust, London, UK. · Centre for Medical Imaging, Universtiy College London, London, UK. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Department of Medical Oncology, Royal Marsden Hospital, London, UK. · Centre for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark. · Computational Health Informatics Program (CHIP), Harvard Medical School, Boston, USA. · MTA-SE-NAP Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary. · Division of Surgery, Department of Surgery and Cancer, Imperial College London, UK. · Department of Urology, Imperial College Healthcare NHS Trust, London, UK. · Pubmed 28961847
  • Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · The Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Epic Sciences, San Diego, CA, USA. · Department Urology, University of Michigan Medical School, Ann Arbor, MI, USA. · Comprehensive Cancer Center, Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Pubmed 27539393
2016
  • Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London The Royal Marsden NHS Foundation Trust, London, UK. · Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London The Royal Marsden NHS Foundation Trust, London, UK · Pubmed 27091809
  • Centre of Evolution and Cancer, The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK; and at The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, 1650 Orleans Street, CRB1-1M45, Baltimore, Maryland 21231, USA. · Pubmed 27804988
  • Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Clinical Academic Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK; Oncogenetics Team, Division of Cancer Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Erasmus University Medical Center, Rotterdam, Netherlands. · Departments of Pathology Urology, Comprehensive Cancer Center and Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Johns Hopkins Hospital, Baltimore, MA, USA. · Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 26074382
  • Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Astex Pharmaceuticals, Cambridge, United Kingdom. · Department of Medicine, University of Washington School of Medicine and GRECC at VAPSHCS Seattle, Washington. Department of Urology, University of Washington School of Medicine and GRECC at VAPSHCS Seattle, Washington. · Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 27197266
  • Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · University of Florence, Florence, Italy. · Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · The Institute of Cancer Research and The Royal Marsden, London, UK. · Pubmed 27191887
  • Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds. · Department of Urology, University Hospital, Bern, Switzerland. · Patient rep, MRC Clinical Trials Unit at UCL, London, UK. · Department of Oncology, Weston Park Hospital, Sheffield & Doncaster, UK. · Kent Oncology Centre, Maidstone Hospital, Maidstone, UK. · Department of Oncology, Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Department of Oncology, Poole Hospital NHS Foundation Trust and Royal Bournemouth Hospital NHS Foundation Trust, Chur, Switzerland. · Kantonsspital Graubünden, Chur, Switzerland. · Department of Oncology, Derby Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Oncology, Cheltenham General Hospital & Hereford County Hospital, UK. · Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Oncology and Haematology Clinical Trials Unit, Queen Alexandra Hospital, Portsmouth, UK. · Department of Oncology, Queen's Hospital, Romford, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Department of Urology, Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Group, Mount Vernon Hospital, Middlesex, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, East Sussex Hospitals Trust, East Sussex, UK. · Department of Oncology, Western General Hospital, Edinburgh, UK. · Centre for Cancer Research and Cell Biology, Queens University Belfast/Belfast City Hospital, Belfast, UK. · Department of Oncology, East Lancashire Hospitals NHS Trust, East Lancashire, UK. · Department of Oncology & Radiotherapy, South Tees NHS Trust, Middlesbrough, UK. · Department of Oncology, Churchill Hospital, Oxford, UK. · Department of Oncology, Sussex Cancer Centre, Brighton, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Royal Devon & Exeter Hospital, Exeter, UK/Torbay Hospital, Torquay, UK. · Department of Oncology, Nottingham University Hospitals NHS trust, Nottingham, UK. · Department of Oncology & Radiotherapy, Clatterbridge Cancer Centre, Wirral, UK. · Department of Oncology, Southend & Basildon Hospitals, Essex, UK. · The South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK. · Pubmed 26719232
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom. · Medical Research Council Clinical Trials Unit, University College, London, United Kingdom. · Department of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Velindre Hospital, Cardiff, United Kingdom. · Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. · Royal Preston Hospital, Preston, United Kingdom. · Cantonal Hospital St Gallen, St Gallen, Switzerland. · Greater Manchester Group, Manchester, United Kingdom. · Leeds Beckett University, Leeds, United Kingdom. · Belfast City Hospital, Belfast, United Kingdom. · Singleton Hospital, Swansea, United Kingdom. · Royal Shrewsbury Hospital, Shrewsbury, United Kingdom. · Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. · CCO Liverpool Warrington Aintree, Liverpool, United Kingdom. · Pubmed 26606329
2015
  • The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK · Division of Medicine, Weill Cornell Medical College, New York, USA. · Pubmed 25862438
  • Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 26065613
  • The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 26025264
  • Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. · Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 25251387
  • Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center · Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College · Xiaoyu Jia, Columbia University, New York, NY · Arturo Molina, Janssen Research & Development, Menlo Park · Weimin Peng, Janssen Research & Development, Los Angeles · Thian Kheoh, Janssen Research & Development, San Diego, CA · Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research · Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom · Robert McCormack, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25800753
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. · The Institute of Cancer Research, London SW7 3RP, UK. Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medicine, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medicine, NY 10021, USA. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Pubmed 26537258
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · The Institute of Cancer Research and the Royal Marsden, London, UK. · Pubmed 25897673
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK. · Department of Medical Cell BioPhysics, MIRA Institute, University of Twente, 7522ND, Enschede, The Netherlands. · 1] Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK [2] Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5NG, UK. · Pubmed 25719830
  • Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 25555314
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 25454616
2014
  • The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Medical Research Council Clinical Trials Unit at University College London, London, UK. Electronic address: · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · University of Bern, Bern, Switzerland. · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Department of Urology, University Hospital, Bern, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Patient representative, Stockton-on-Tees, UK. · Patient representative, Northampton, UK. · University of Warwick, Warwick, UK. · Pubmed 24985962
  • Prostate Targeted Therapy Group, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Division of Cancer Therapeutics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Pubmed 24840076
  • The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 24685433
  • The Institute of Cancer Research, London SM2 5NG, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medical College, New York, NY 10021, USA. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Pubmed 25232177
  • The Royal Marsden NHS Trust and The Institute of Cancer Research, Drug Development Unit, Downs Road, Sutton, Surrey SM2 5PT, UK. Electronic address: · Pubmed 24739898
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Guy's and St. Thomas' NHS Foundation Trust, Great Maze Pond, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 24074764
  • The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. · Guy's and St. Thomas NHS Foundation Trust, United Kingdom. · The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. Electronic address: · Pubmed 24433842
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK. · Academic Urology Unit, Sutton, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, UK. · Pubmed 24300975
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 24295792
2011
  • Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, United Kingdom. · Pubmed 21680542
  • Section of Medicine, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 21372223
2009
  • Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 19470933
2008
  • The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 18495790
  • Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 18645193
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom · and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
2016
  • From Weill Cornell Medicine, New York, NY, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY; The Institute of Cancer Research, London, United Kingdom, The Royal Marsden Hospital, London, United Kingdom. · Pubmed 27249694
2015
  • From the Institute of Cancer Research (J.M., S.C., S.S., S.M., H.M., R.P.-L., D.N.R., A.O., N.T., G.B., N.P., P.F., A.G., I.F., C.P., G.S., D.B., J.G., Z.Z., C.T.W., R.F., R.R., B.E., G.F., D. Roda, W.Y., R.B., H.P., R.A., A.S., R.E., G.A., C.J.L., A.A., E.H., J.S.B.), the Royal Marsden NHS Foundation Trust (J.M., S.S., R.P.-L., A.O., N.T., D.B., Z.Z., R.F., D. Roda, R.E., G.A., J.S.B.), and University College London Hospital (U.M.), London, Queen's University, Belfast (S.J.), University of Leeds, Leeds (C.R.), Churchill Hospital, Oxford (A.P.), University of Liverpool, Liverpool (S.H.), Beatson West of Scotland Cancer Centre, Glasgow (R.J.), and Christie Hospital, Manchester (T.E.) - all in the United Kingdom · the University of Michigan, Ann Arbor (D. Robinson, Y.-M.W., X.C., L.P.K., F.Y.F., A.M.C.) · Weill Cornell Medical College, New York (M.A.R.) · and Thomas Jefferson University, Philadelphia (K.E.K.). · Pubmed 26510020
2013
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 23470964
  • 1] Prostate Cancer Targeted Therapy Group and Drug Development Unit, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK [2] Memorial Sloan-Kettering Cancer Center (MSKCC) and Weill Cornell Medical College, Center for Prostate and Urologic Cancers, New York, NY, USA. · Pubmed 24169353
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23807167
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23928659
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23313031
2012
  • Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK. · Pubmed 22249187
2011
  • Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, UK. · Pubmed 21498309
2010
  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20159823
  • Drug Development Unit, Royal Marsden National Health Service Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19608618
2008
  • The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK. · Pubmed 18619560
Probable:    University College London      
2015
  • Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 25555314
2014
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom · and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
2015
  • From the Institute of Cancer Research (J.M., S.C., S.S., S.M., H.M., R.P.-L., D.N.R., A.O., N.T., G.B., N.P., P.F., A.G., I.F., C.P., G.S., D.B., J.G., Z.Z., C.T.W., R.F., R.R., B.E., G.F., D. Roda, W.Y., R.B., H.P., R.A., A.S., R.E., G.A., C.J.L., A.A., E.H., J.S.B.), the Royal Marsden NHS Foundation Trust (J.M., S.S., R.P.-L., A.O., N.T., D.B., Z.Z., R.F., D. Roda, R.E., G.A., J.S.B.), and University College London Hospital (U.M.), London, Queen's University, Belfast (S.J.), University of Leeds, Leeds (C.R.), Churchill Hospital, Oxford (A.P.), University of Liverpool, Liverpool (S.H.), Beatson West of Scotland Cancer Centre, Glasgow (R.J.), and Christie Hospital, Manchester (T.E.) - all in the United Kingdom · the University of Michigan, Ann Arbor (D. Robinson, Y.-M.W., X.C., L.P.K., F.Y.F., A.M.C.) · Weill Cornell Medical College, New York (M.A.R.) · and Thomas Jefferson University, Philadelphia (K.E.K.). · Pubmed 26510020
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 99 total) written by Gerhardt Attard about Prostatic Neoplasms:

  • Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. 2017
  • Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy. 2017
  • Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study. 2017
  • Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone. 2017
  • Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters. 2017
  • Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial. 2017
  • Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer. 2017
  • Diagnostic Gleason score and castration-resistant prostate cancer. 2016
  • Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide. 2016
  • Prostate cancer. 2016
Show List of Full Article Records
Google Searches

Learn more about Gerhardt Attard using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of London
Royal Marsden Hospital and Trust
University College London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of London
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Research Data Management and Statistics Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, Hospital Ramón y Cajal, Madrid. · Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Integrative Biology, University of Trento, Trento, Italy. · Oncology Unit, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona. · Department of Medical Oncology, H. Universitario Lucus Augusti, Lugo. · Department of Medical Oncology, H.U. Son Espases Mallorca, Mallorca. · Department of Medical Oncology, IDIBAPS Hospital Clinic, Barcelona. · Department of Medical Oncology, Hospital de Orense, Orense. · Department of Medical Oncology, Hospital Universitario Reina Sofía, Córdoba. · Department of Medical Oncology, Instituto Valenciano de Oncología Valencia, Valencia. · Department of Medical Oncology, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla. · Department of Medical Oncology, H.U. Parc Taulí, Sabadell, Barcelona. · Department of Medical Oncology, Hospital de León, León. · Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza. · Department of Medical Oncology, Hospital Regional y Hospital Virgen de la Victoria, Malaga. · Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain. · Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. · Institute for Precision Medicine, Weill Cornell Medicine, New York, USA. · Department of Medical Oncology, Universidad Católica San Antonio de Murcia-UCAM, Murcia, Spain. · Pubmed 28472366
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Translational Cancer Therapeutics Laboratory, UCL Cancer Institute, London, UK. · Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK. · Bill Lyons Informatics Centre, UCL Cancer Institute, London, UK. · Division of Cancer Studies, King's College London, London, UK. · Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK. · Division of Surgery and Interventional Science, University College London, London, UK. · Cancer Immunology Unit, UCL Cancer Institute, London, UK. · Research Department of Haematology, UCL Cancer Institute, London, UK. · Department of Histopathology, University College London Hospitals NHS Foundation Trust, London, UK. · Definiens AG, Munich, Germany. · Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK. · Cancer Genomics Laboratory, The Francis Crick Institute, London, UK. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK. · The Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London, UK. · Department of Urology, UCLH NHS Foundation Trust, London, UK. · Centre for Medical Imaging, Universtiy College London, London, UK. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Department of Medical Oncology, Royal Marsden Hospital, London, UK. · Centre for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark. · Computational Health Informatics Program (CHIP), Harvard Medical School, Boston, USA. · MTA-SE-NAP Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary. · Division of Surgery, Department of Surgery and Cancer, Imperial College London, UK. · Department of Urology, Imperial College Healthcare NHS Trust, London, UK. · Pubmed 28961847
  • Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · The Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Epic Sciences, San Diego, CA, USA. · Department Urology, University of Michigan Medical School, Ann Arbor, MI, USA. · Comprehensive Cancer Center, Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Pubmed 27539393
2016
  • Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London The Royal Marsden NHS Foundation Trust, London, UK. · Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London The Royal Marsden NHS Foundation Trust, London, UK · Pubmed 27091809
  • Centre of Evolution and Cancer, The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK; and at The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, 1650 Orleans Street, CRB1-1M45, Baltimore, Maryland 21231, USA. · Pubmed 27804988
  • Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Clinical Academic Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK; Oncogenetics Team, Division of Cancer Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Erasmus University Medical Center, Rotterdam, Netherlands. · Departments of Pathology Urology, Comprehensive Cancer Center and Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Johns Hopkins Hospital, Baltimore, MA, USA. · Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 26074382
  • Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Astex Pharmaceuticals, Cambridge, United Kingdom. · Department of Medicine, University of Washington School of Medicine and GRECC at VAPSHCS Seattle, Washington. Department of Urology, University of Washington School of Medicine and GRECC at VAPSHCS Seattle, Washington. · Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 27197266
  • Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · University of Florence, Florence, Italy. · Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · The Institute of Cancer Research and The Royal Marsden, London, UK. · Pubmed 27191887
  • Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds. · Department of Urology, University Hospital, Bern, Switzerland. · Patient rep, MRC Clinical Trials Unit at UCL, London, UK. · Department of Oncology, Weston Park Hospital, Sheffield & Doncaster, UK. · Kent Oncology Centre, Maidstone Hospital, Maidstone, UK. · Department of Oncology, Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Department of Oncology, Poole Hospital NHS Foundation Trust and Royal Bournemouth Hospital NHS Foundation Trust, Chur, Switzerland. · Kantonsspital Graubünden, Chur, Switzerland. · Department of Oncology, Derby Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Oncology, Cheltenham General Hospital & Hereford County Hospital, UK. · Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Oncology and Haematology Clinical Trials Unit, Queen Alexandra Hospital, Portsmouth, UK. · Department of Oncology, Queen's Hospital, Romford, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Department of Urology, Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Group, Mount Vernon Hospital, Middlesex, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, East Sussex Hospitals Trust, East Sussex, UK. · Department of Oncology, Western General Hospital, Edinburgh, UK. · Centre for Cancer Research and Cell Biology, Queens University Belfast/Belfast City Hospital, Belfast, UK. · Department of Oncology, East Lancashire Hospitals NHS Trust, East Lancashire, UK. · Department of Oncology & Radiotherapy, South Tees NHS Trust, Middlesbrough, UK. · Department of Oncology, Churchill Hospital, Oxford, UK. · Department of Oncology, Sussex Cancer Centre, Brighton, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Royal Devon & Exeter Hospital, Exeter, UK/Torbay Hospital, Torquay, UK. · Department of Oncology, Nottingham University Hospitals NHS trust, Nottingham, UK. · Department of Oncology & Radiotherapy, Clatterbridge Cancer Centre, Wirral, UK. · Department of Oncology, Southend & Basildon Hospitals, Essex, UK. · The South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK. · Pubmed 26719232
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom. · Medical Research Council Clinical Trials Unit, University College, London, United Kingdom. · Department of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Velindre Hospital, Cardiff, United Kingdom. · Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. · Royal Preston Hospital, Preston, United Kingdom. · Cantonal Hospital St Gallen, St Gallen, Switzerland. · Greater Manchester Group, Manchester, United Kingdom. · Leeds Beckett University, Leeds, United Kingdom. · Belfast City Hospital, Belfast, United Kingdom. · Singleton Hospital, Swansea, United Kingdom. · Royal Shrewsbury Hospital, Shrewsbury, United Kingdom. · Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. · CCO Liverpool Warrington Aintree, Liverpool, United Kingdom. · Pubmed 26606329
2015
  • The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK · Division of Medicine, Weill Cornell Medical College, New York, USA. · Pubmed 25862438
  • Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 26065613
  • The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 26025264
  • Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. · Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 25251387
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. · The Institute of Cancer Research, London SW7 3RP, UK. Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medicine, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medicine, NY 10021, USA. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Pubmed 26537258
  • Genentech Inc., South San Francisco, CA, USA. · The Royal Marsden National Health Service (NHS) Foundation Trust, Sutton, Surrey, UK. · The Institute of Cancer Research, London, UK. · Epic Sciences Inc., San Diego, CA, USA. · Core Diagnostics, Palo Alto, CA, USA. · Pubmed 26379078
  • The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK. · Pubmed 26032550
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · The Institute of Cancer Research and the Royal Marsden, London, UK. · Pubmed 25897673
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK. · Department of Medical Cell BioPhysics, MIRA Institute, University of Twente, 7522ND, Enschede, The Netherlands. · 1] Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK [2] Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5NG, UK. · Pubmed 25719830
  • Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 25555314
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 25454616
2014
  • The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Medical Research Council Clinical Trials Unit at University College London, London, UK. Electronic address: · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · University of Bern, Bern, Switzerland. · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Department of Urology, University Hospital, Bern, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Patient representative, Stockton-on-Tees, UK. · Patient representative, Northampton, UK. · University of Warwick, Warwick, UK. · Pubmed 24985962
  • Prostate Targeted Therapy Group, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Division of Cancer Therapeutics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Pubmed 24840076
  • The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 24685433
  • The Institute of Cancer Research, London SM2 5NG, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medical College, New York, NY 10021, USA. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Pubmed 25232177
  • The Royal Marsden NHS Trust and The Institute of Cancer Research, Drug Development Unit, Downs Road, Sutton, Surrey SM2 5PT, UK. Electronic address: · Pubmed 24739898
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Guy's and St. Thomas' NHS Foundation Trust, Great Maze Pond, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 24074764
  • The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. · Guy's and St. Thomas NHS Foundation Trust, United Kingdom. · The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. Electronic address: · Pubmed 24433842
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK. · Academic Urology Unit, Sutton, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, UK. · Pubmed 24300975
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 24295792
2012
  • The Institute of Cancer Research, Sutton, Surrey SM2 5PT, UK. · Pubmed 22170708
2011
  • Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, United Kingdom. · Pubmed 21680542
  • Section of Medicine, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 21372223
2009
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 19509232
  • The Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK. · Pubmed 19962664
  • The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 19339269
2008
  • Institute of Cancer Research, Male Urological Cancer Research Centre, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK. · Pubmed 18594527
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom · and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
2016
  • From Weill Cornell Medicine, New York, NY, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY; The Institute of Cancer Research, London, United Kingdom, The Royal Marsden Hospital, London, United Kingdom. · Pubmed 27249694
2015
  • From the Institute of Cancer Research (J.M., S.C., S.S., S.M., H.M., R.P.-L., D.N.R., A.O., N.T., G.B., N.P., P.F., A.G., I.F., C.P., G.S., D.B., J.G., Z.Z., C.T.W., R.F., R.R., B.E., G.F., D. Roda, W.Y., R.B., H.P., R.A., A.S., R.E., G.A., C.J.L., A.A., E.H., J.S.B.), the Royal Marsden NHS Foundation Trust (J.M., S.S., R.P.-L., A.O., N.T., D.B., Z.Z., R.F., D. Roda, R.E., G.A., J.S.B.), and University College London Hospital (U.M.), London, Queen's University, Belfast (S.J.), University of Leeds, Leeds (C.R.), Churchill Hospital, Oxford (A.P.), University of Liverpool, Liverpool (S.H.), Beatson West of Scotland Cancer Centre, Glasgow (R.J.), and Christie Hospital, Manchester (T.E.) - all in the United Kingdom · the University of Michigan, Ann Arbor (D. Robinson, Y.-M.W., X.C., L.P.K., F.Y.F., A.M.C.) · Weill Cornell Medical College, New York (M.A.R.) · and Thomas Jefferson University, Philadelphia (K.E.K.). · Pubmed 26510020
  • Section of Medicine, The Institute of Cancer Research, London, UK. · Pubmed 25041380
2013
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 23470964
  • 1] Prostate Cancer Targeted Therapy Group and Drug Development Unit, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK [2] Memorial Sloan-Kettering Cancer Center (MSKCC) and Weill Cornell Medical College, Center for Prostate and Urologic Cancers, New York, NY, USA. · Pubmed 24169353
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23807167
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23928659
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, United Kingdom. · Pubmed 23565754
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23313031
2012
  • Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK. · Pubmed 22249187
  • Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom. · Pubmed 21986558
  • The Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 22460813
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 22411952
2011
  • Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, UK. · Pubmed 21498309
2010
  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20159823
  • Drug Development Unit, Royal Marsden National Health Service Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19608618
  • Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. · Pubmed 20177423
2009
  • Institute of Cancer Research, Male Urological Cancer Research Centre, Sutton, Surrey, UK. · Pubmed 19040532
2008
  • Prostate Stem Cell Laboratory, Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 18398820
Royal Marsden Hospital and Trust
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Research Data Management and Statistics Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, Hospital Ramón y Cajal, Madrid. · Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, IMIB-Universidad de Murcia, Murcia. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Centre for Integrative Biology, University of Trento, Trento, Italy. · Oncology Unit, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona. · Department of Medical Oncology, H. Universitario Lucus Augusti, Lugo. · Department of Medical Oncology, H.U. Son Espases Mallorca, Mallorca. · Department of Medical Oncology, IDIBAPS Hospital Clinic, Barcelona. · Department of Medical Oncology, Hospital de Orense, Orense. · Department of Medical Oncology, Hospital Universitario Reina Sofía, Córdoba. · Department of Medical Oncology, Instituto Valenciano de Oncología Valencia, Valencia. · Department of Medical Oncology, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla. · Department of Medical Oncology, H.U. Parc Taulí, Sabadell, Barcelona. · Department of Medical Oncology, Hospital de León, León. · Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza. · Department of Medical Oncology, Hospital Regional y Hospital Virgen de la Victoria, Malaga. · Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain. · Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK. · Institute for Precision Medicine, Weill Cornell Medicine, New York, USA. · Department of Medical Oncology, Universidad Católica San Antonio de Murcia-UCAM, Murcia, Spain. · Pubmed 28472366
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Translational Cancer Therapeutics Laboratory, UCL Cancer Institute, London, UK. · Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK. · Bill Lyons Informatics Centre, UCL Cancer Institute, London, UK. · Division of Cancer Studies, King's College London, London, UK. · Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK. · Division of Surgery and Interventional Science, University College London, London, UK. · Cancer Immunology Unit, UCL Cancer Institute, London, UK. · Research Department of Haematology, UCL Cancer Institute, London, UK. · Department of Histopathology, University College London Hospitals NHS Foundation Trust, London, UK. · Definiens AG, Munich, Germany. · Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK. · Cancer Genomics Laboratory, The Francis Crick Institute, London, UK. · Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK. · The Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London, UK. · Department of Urology, UCLH NHS Foundation Trust, London, UK. · Centre for Medical Imaging, Universtiy College London, London, UK. · Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. · Department of Medical Oncology, Royal Marsden Hospital, London, UK. · Centre for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark. · Computational Health Informatics Program (CHIP), Harvard Medical School, Boston, USA. · MTA-SE-NAP Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary. · Division of Surgery, Department of Surgery and Cancer, Imperial College London, UK. · Department of Urology, Imperial College Healthcare NHS Trust, London, UK. · Pubmed 28961847
  • Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · The Institute of Cancer Research, London, UK. · Royal Marsden NHS Foundation Trust, London, UK. · Epic Sciences, San Diego, CA, USA. · Department Urology, University of Michigan Medical School, Ann Arbor, MI, USA. · Comprehensive Cancer Center, Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Pubmed 27539393
2016
  • Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London The Royal Marsden NHS Foundation Trust, London, UK. · Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London The Royal Marsden NHS Foundation Trust, London, UK · Pubmed 27091809
  • Centre of Evolution and Cancer, The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK; and at The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, 1650 Orleans Street, CRB1-1M45, Baltimore, Maryland 21231, USA. · Pubmed 27804988
  • Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Academic Urology Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Clinical Academic Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK; Oncogenetics Team, Division of Cancer Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Erasmus University Medical Center, Rotterdam, Netherlands. · Departments of Pathology Urology, Comprehensive Cancer Center and Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA. · Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada. · Division of Medical Oncology, Johns Hopkins Hospital, Baltimore, MA, USA. · Division of Clinical Studies, The Institute of Cancer Research, London, UK; Prostate Cancer Targeted Therapy Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 26074382
  • Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Astex Pharmaceuticals, Cambridge, United Kingdom. · Department of Medicine, University of Washington School of Medicine and GRECC at VAPSHCS Seattle, Washington. Department of Urology, University of Washington School of Medicine and GRECC at VAPSHCS Seattle, Washington. · Division of Clinical Studies and Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, United Kingdom. Prostate Cancer Targeted Therapies Group, Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 27197266
  • Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · University of Florence, Florence, Italy. · Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · The Institute of Cancer Research and The Royal Marsden, London, UK. · Pubmed 27191887
  • Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, London, UK. · MRC Clinical Trials Unit at UCL, London, UK. · Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK. · Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds. · Department of Urology, University Hospital, Bern, Switzerland. · Patient rep, MRC Clinical Trials Unit at UCL, London, UK. · Department of Oncology, Weston Park Hospital, Sheffield & Doncaster, UK. · Kent Oncology Centre, Maidstone Hospital, Maidstone, UK. · Department of Oncology, Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK. · Department of Oncology, Poole Hospital NHS Foundation Trust and Royal Bournemouth Hospital NHS Foundation Trust, Chur, Switzerland. · Kantonsspital Graubünden, Chur, Switzerland. · Department of Oncology, Derby Hospitals NHS Foundation Trust, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's Hospital, London, UK. · Department of Oncology, Cheltenham General Hospital & Hereford County Hospital, UK. · Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Oncology and Haematology Clinical Trials Unit, Queen Alexandra Hospital, Portsmouth, UK. · Department of Oncology, Queen's Hospital, Romford, UK. · Beacon Centre, Musgrove Park Hospital, Taunton, UK. · Department of Urology, Hull & East Yorkshire Hospitals NHS Trust, Hull, UK. · Mount Vernon Group, Mount Vernon Hospital, Middlesex, UK. · Department of Oncology, Royal Surrey County Hospital, Guildford, UK. · Department of Oncology, East Sussex Hospitals Trust, East Sussex, UK. · Department of Oncology, Western General Hospital, Edinburgh, UK. · Centre for Cancer Research and Cell Biology, Queens University Belfast/Belfast City Hospital, Belfast, UK. · Department of Oncology, East Lancashire Hospitals NHS Trust, East Lancashire, UK. · Department of Oncology & Radiotherapy, South Tees NHS Trust, Middlesbrough, UK. · Department of Oncology, Churchill Hospital, Oxford, UK. · Department of Oncology, Sussex Cancer Centre, Brighton, UK. · Department of Oncology, Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, UK. · Department of Oncology, Royal Devon & Exeter Hospital, Exeter, UK/Torbay Hospital, Torquay, UK. · Department of Oncology, Nottingham University Hospitals NHS trust, Nottingham, UK. · Department of Oncology & Radiotherapy, Clatterbridge Cancer Centre, Wirral, UK. · Department of Oncology, Southend & Basildon Hospitals, Essex, UK. · The South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK. · Pubmed 26719232
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom. · Medical Research Council Clinical Trials Unit, University College, London, United Kingdom. · Department of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom. · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom. · Velindre Hospital, Cardiff, United Kingdom. · Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom. · Royal Preston Hospital, Preston, United Kingdom. · Cantonal Hospital St Gallen, St Gallen, Switzerland. · Greater Manchester Group, Manchester, United Kingdom. · Leeds Beckett University, Leeds, United Kingdom. · Belfast City Hospital, Belfast, United Kingdom. · Singleton Hospital, Swansea, United Kingdom. · Royal Shrewsbury Hospital, Shrewsbury, United Kingdom. · Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom. · CCO Liverpool Warrington Aintree, Liverpool, United Kingdom. · Pubmed 26606329
2015
  • The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK · Division of Medicine, Weill Cornell Medical College, New York, USA. · Pubmed 25862438
  • Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 26065613
  • The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. · The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 26025264
  • Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. · Institute of Cancer Research, Cancer Therapeutics, 15 Cotswold Rd, Sutton, Surrey SM25NG, UK; Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Pubmed 25251387
  • Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center · Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College · Xiaoyu Jia, Columbia University, New York, NY · Arturo Molina, Janssen Research & Development, Menlo Park · Weimin Peng, Janssen Research & Development, Los Angeles · Thian Kheoh, Janssen Research & Development, San Diego, CA · Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research · Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom · Robert McCormack, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25800753
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. · The Institute of Cancer Research, London SW7 3RP, UK. Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medicine, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medicine, NY 10021, USA. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Pubmed 26537258
  • Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA; Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Laboratory Medicine, University of Washington, Seattle, WA 98195, USA. · Cancer Biomarkers Team, Division of Clinical Studies, The Institute of Cancer Research, London SM2 5NG, UK; Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, London SM2 5NG, UK. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; New York Presbyterian Hospital, New York, NY 10021, USA; Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Computational Biology Program, Public Health Sciences Division and Basic Science Division, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA 98109, USA. · Prostate Cancer Clinical Trials Consortium, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Internal Medicine, Division of Hematology Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Genitourinary Oncology Service, Department of Medicine, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Interventional Radiology, Department of Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pathology, Brigham & Women's Hospital, Boston, MA 02115, USA. · Division of Hematology-Oncology, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. · Department of Musculoskeletal Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA. · Department of Radiology, University of Washington, Seattle, WA 98109, USA. · Department of Pathology, University of Washington Medical Center, Seattle, WA 98109, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Laboratory of Computational Oncology, CIBIO, Centre for Integrative Biology, University of Trento, 38123 Mattarello TN, Italy. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Division of Interventional Radiology, Department of Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Department of Physiology & Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Precision Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA; Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Medical College of Cornell University, New York, NY 10021, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. · The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Medicine and VAPSHCS, University of Washington, Seattle, WA 98109, USA; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Meyer Cancer, Weill Medical College of Cornell University, New York, NY 10021, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: · Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: · Pubmed 26000489
  • Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. · The Institute of Cancer Research and the Royal Marsden, London, UK. · Pubmed 25897673
  • Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK. · Department of Medical Cell BioPhysics, MIRA Institute, University of Twente, 7522ND, Enschede, The Netherlands. · 1] Section of Medicine, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK [2] Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5NG, UK. · Pubmed 25719830
  • Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 25555314
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 25454616
2014
  • The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Medical Research Council Clinical Trials Unit at University College London, London, UK. Electronic address: · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Department of Urology, The Christie NHS Foundation Trust, Manchester, UK. · University of Bern, Bern, Switzerland. · Medical Research Council Clinical Trials Unit at University College London, London, UK. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · Department of Urology, University Hospital, Bern, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Patient representative, Stockton-on-Tees, UK. · Patient representative, Northampton, UK. · University of Warwick, Warwick, UK. · Pubmed 24985962
  • Prostate Targeted Therapy Group, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Division of Cancer Therapeutics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, 15 Cotswold Road, Sutton, London SM2 5NG, UK. · Pubmed 24840076
  • The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. Electronic address: · Pubmed 24685433
  • The Institute of Cancer Research, London SM2 5NG, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medical College, New York, NY 10021, USA. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Pubmed 25232177
  • The Royal Marsden NHS Trust and The Institute of Cancer Research, Drug Development Unit, Downs Road, Sutton, Surrey SM2 5PT, UK. Electronic address: · Pubmed 24739898
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Guy's and St. Thomas' NHS Foundation Trust, Great Maze Pond, London, UK. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 24074764
  • The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. · Guy's and St. Thomas NHS Foundation Trust, United Kingdom. · The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. Electronic address: · Pubmed 24433842
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, UK. · Academic Urology Unit, Sutton, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, UK. · Pubmed 24300975
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 24295792
2011
  • Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, United Kingdom. · Pubmed 21680542
  • Section of Medicine, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 21372223
2009
  • Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 19470933
2008
  • The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 18495790
  • Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom. · Pubmed 18645193
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom · and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
2016
  • From Weill Cornell Medicine, New York, NY, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY; The Institute of Cancer Research, London, United Kingdom, The Royal Marsden Hospital, London, United Kingdom. · Pubmed 27249694
2015
  • From the Institute of Cancer Research (J.M., S.C., S.S., S.M., H.M., R.P.-L., D.N.R., A.O., N.T., G.B., N.P., P.F., A.G., I.F., C.P., G.S., D.B., J.G., Z.Z., C.T.W., R.F., R.R., B.E., G.F., D. Roda, W.Y., R.B., H.P., R.A., A.S., R.E., G.A., C.J.L., A.A., E.H., J.S.B.), the Royal Marsden NHS Foundation Trust (J.M., S.S., R.P.-L., A.O., N.T., D.B., Z.Z., R.F., D. Roda, R.E., G.A., J.S.B.), and University College London Hospital (U.M.), London, Queen's University, Belfast (S.J.), University of Leeds, Leeds (C.R.), Churchill Hospital, Oxford (A.P.), University of Liverpool, Liverpool (S.H.), Beatson West of Scotland Cancer Centre, Glasgow (R.J.), and Christie Hospital, Manchester (T.E.) - all in the United Kingdom · the University of Michigan, Ann Arbor (D. Robinson, Y.-M.W., X.C., L.P.K., F.Y.F., A.M.C.) · Weill Cornell Medical College, New York (M.A.R.) · and Thomas Jefferson University, Philadelphia (K.E.K.). · Pubmed 26510020
2013
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, United Kingdom. · Pubmed 23470964
  • 1] Prostate Cancer Targeted Therapy Group and Drug Development Unit, Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK [2] Memorial Sloan-Kettering Cancer Center (MSKCC) and Weill Cornell Medical College, Center for Prostate and Urologic Cancers, New York, NY, USA. · Pubmed 24169353
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23807167
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23928659
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Pubmed 23313031
2012
  • Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK. · Pubmed 22249187
2011
  • Cancer Research UK Clinical Magnetic Resonance Research Group, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, UK. · Pubmed 21498309
2010
  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · Pubmed 20159823
  • Drug Development Unit, Royal Marsden National Health Service Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Pubmed 19608618
2008
  • The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK. · Pubmed 18619560
Unspecified
2017
  • Malcolm D. Mason, Cardiff University School of Medicine, Velindre Hospital · Jim Barber, Velindre Cancer Centre, Cardiff · Noel W. Clarke, The Christie and Salford Royal NHS Foundation Trusts · John Logue, Christie Hospital, Manchester · Nicholas D. James, Institute of Cancer and Genomic Sciences · Emilio Porfiri, The Medical School, University of Birmingham · Nicholas D. James, Queen Elizabeth Hospital · Emilio Porfiri, University Hospitals Birmingham NHS Foundation Trust, Birmingham · David P. Dearnaley, Gerhardt Attard, and Christopher C. Parker, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust · Melissa R. Spears, Alastair W.S. Ritchie, Francesca Schiavone, David Matheson, Robin Millman, Clare Gilson, Mahesh K.B. Parmar, and Matthew R. Sydes, MRC Clinical Trials Unit at UCL, London · William Cross, Leeds Teaching Hospitals NHS Trust, Leeds · Rob J. Jones and J. Martin Russell, University of Glasgow · Rob J. Jones and Jan Wallace, Beatson West of Scotland Cancer Centre, Glasgow · Azman Ibrahim, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral · Anna Lydon, Torbay District Hospital, Torquay · Ashok D. Nikapota, Sussex Cancer Centre, Brighton · Ashok D. Nikapota, Worthing Hospital, Worthing · Joe M. O'Sullivan, Centre for Cancer Research and Cell Biology, Queen's University, Belfast · Andrew Protheroe, Churchill Hospital, Oxford · Narayanan Nair Srihari, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury · David Tsang, Southend Hospital, Southend-on-Sea · David Tsang, Basildon Hospital, Basildon · John Wagstaff, The South West Wales Cancer Institute · John Wagstaff, Swansea University College of Medicine, Swansea · Catherine Walmsley, Royal Preston Hospital, Preston, United Kingdom · George N. Thalmann, University Hospital · Estelle Cassoly, SAKK Coordinating Center, Berne · and Cyrill A. Rentsch, University Hospital Basel, Basel, Switzerland. · Pubmed 28300506
2016
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden National Health Services Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Oncohematology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Eastern Health Medicine School, Monash University, Box Hill, VC, Australia. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden National Health Services Foundation Trust and The Institute of Cancer Research, Sutton, UK. Electronic address: · Pubmed 27246360
  • The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: · Pubmed 26965561
2015
  • Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Surrey, UK. · Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Pubmed 24837363
  • Howard I. Scher, Glenn Heller, Daniel C. Danila, and Martin Fleisher, Memorial Sloan Kettering Cancer Center · Howard I. Scher and Daniel C. Danila, Weill Cornell Medical College · Xiaoyu Jia, Columbia University, New York, NY · Arturo Molina, Janssen Research & Development, Menlo Park · Weimin Peng, Janssen Research & Development, Los Angeles · Thian Kheoh, Janssen Research & Development, San Diego, CA · Gerhardt Attard, Shahneen K. Sandhu, David Olmos, Ruth Riisnaes, and Johann S. de Bono, Institute of Cancer Research · Gerhardt Attard, Shahneen K. Sandhu, David Olmos, and Johann S. de Bono, Royal Marsden Hospital, Sutton, United Kingdom · Robert McCormack, Janssen Research & Development, Raritan, NJ · and Tomasz Burzykowski and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25800753
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
2014
  • Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton SM2 5PT, Surrey, UK. · 1] Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton SM2 5PT, Surrey, UK [2] Kantonsspital St. Gallen, Department of Oncology and Haematology, Rorschacherstrasse 95, CH-9007 St. Gallen, Switzerland. · Academic Urology Unit, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton SM2 5PT, Surrey, UK. · Kantonsspital St. Gallen, Department of Oncology and Haematology, Rorschacherstrasse 95, CH-9007 St. Gallen, Switzerland. · Pubmed 25314055
2009
2014
2013
  • Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Pubmed 23204221
2012
  • Section of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Pubmed 22771826
  • Drug Development Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK. · Pubmed 23059046
2010
  • The Institute of Cancer Research, Male Urological Cancer Research Centre, Surrey, UK. · Pubmed 20104229
2009
  • Drug Development Unit, The Royal Marsden NHS Foundation Trust, Sutton, UK. · Pubmed 18695026
2008
  • Institute of Cancer Research and the Royal Marsden Hospital, Surrey, UK. · Pubmed 18985049
University College London
2015
  • Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Diagnostic Radiology Department, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, UK. Electronic address: · Pubmed 25555314
2014
  • Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. · Prostate Cancer Targeted Therapy Group and Academic Urology Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, Surrey, UK. Electronic address: · Pubmed 24411987
2017
  • From the Institute of Cancer and Genomic Sciences, University of Birmingham (N.D.J.), and University Hospital Birmingham (A.Z.), Birmingham, the Institute of Cancer Research (J.S.B., D.P.D., G.A.), Medical Research Council Clinical Trials Unit at University College London (M.R. Spears, C.L.A., C.G., C.B., M.K.B.P., M.R. Sydes), King's College London and Guy's and St. Thomas' NHS Foundation Trust (S.C.), and Royal Marsden NHS Foundation Trust (C.C.P.), London, Salford Royal NHS Foundation Trust, Salford (N.W.C.), Cardiff University School of Medicine (M.D.M.) and Velindre Cancer Centre (J.F.L.), Cardiff, Gloucestershire Royal Hospital (A.W.S.R.) and Gloucestershire Hospitals NHS Foundation Trust (J.B.), Gloucester, University of Glasgow, Glasgow (R.J.J., J.M.R.), St. James's University Hospital, Leeds (W.R.C.), University Hospital of North-Midlands, Stoke-on-Trent (F.A.), Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter (S.A.), Rosemere Cancer Centre, Royal Preston Hospital, Preston (A.J.B.), Dorset Cancer Centre, Poole Hospital, Poole (S.B.), Royal Derby Hospital, Derby (P.C.), Weston Park Hospital, Sheffield (C.F.), Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth (J.G.), Musgrove Park Hospital, Taunton (E.G.), Hull and East Yorkshire Hospitals NHS Trust, Hull (M.H.), Mount Vernon Cancer Centre, Northwood (P.J.H.), Clatterbridge Cancer Centre, Wirral (Z.I.M.), Brighton and Sussex University Hospitals NHS Trust (F.M.) and Sussex Cancer Centre, Royal Sussex County Hospital (A.R.), Brighton, NHS Highland, Inverness (N.M.), Royal Surrey County Hospital, Guildford (J.M.-K.), Northern Ireland Cancer and Queens University, Belfast (J.O.), Lancashire Teaching Hospitals NHS Trust, Preston (O.P.), Churchill Hospital, Oxford (A.P.), Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury (N.N.S.), East Kent Hospitals NHS Trust, Canterbury (C.T.), Swansea University College of Medicine, Swansea (J. Wagstaff), and Christie NHS Foundation Trust, Manchester (J. Wylie) - all in the United Kingdom · and the Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen (S.G.), and University Hospital of Lausanne, Lausanne (D.R.B.) - both in Switzerland. Two of the authors (D.M., R.M.) were unaffiliated lay members of the STAMPEDE investigators. · Pubmed 28578639
2015
  • From the Institute of Cancer Research (J.M., S.C., S.S., S.M., H.M., R.P.-L., D.N.R., A.O., N.T., G.B., N.P., P.F., A.G., I.F., C.P., G.S., D.B., J.G., Z.Z., C.T.W., R.F., R.R., B.E., G.F., D. Roda, W.Y., R.B., H.P., R.A., A.S., R.E., G.A., C.J.L., A.A., E.H., J.S.B.), the Royal Marsden NHS Foundation Trust (J.M., S.S., R.P.-L., A.O., N.T., D.B., Z.Z., R.F., D. Roda, R.E., G.A., J.S.B.), and University College London Hospital (U.M.), London, Queen's University, Belfast (S.J.), University of Leeds, Leeds (C.R.), Churchill Hospital, Oxford (A.P.), University of Liverpool, Liverpool (S.H.), Beatson West of Scotland Cancer Centre, Glasgow (R.J.), and Christie Hospital, Manchester (T.E.) - all in the United Kingdom · the University of Michigan, Ann Arbor (D. Robinson, Y.-M.W., X.C., L.P.K., F.Y.F., A.M.C.) · Weill Cornell Medical College, New York (M.A.R.) · and Thomas Jefferson University, Philadelphia (K.E.K.). · Pubmed 26510020
University of Trento
2015
  • Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. · The Institute of Cancer Research, London SW7 3RP, UK. Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola 47014, Italy. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medicine, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medicine, NY 10021, USA. · The Institute of Cancer Research, London SW7 3RP, UK. The Royal Marsden NHS Foundation Trust, London SM2 5PT, UK. · Pubmed 26537258
2014
  • The Institute of Cancer Research, London SM2 5NG, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Centre for Integrative Biology, University of Trento, Trento 38123, Italy. Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10021, USA. Institute for Precision Medicine, Weill Cornell Medical College, New York, NY 10021, USA. · The Institute of Cancer Research, London SM2 5NG, UK. Royal Marsden National Health Service Foundation Trust, London SM2 5PT, UK. · Pubmed 25232177
2013
  • Centre for Integrative Biology, University of Trento, Povo, Trento, Italy. · Pubmed 23921739
29 Other Locations Show
Yearly article counts 0710181412867107
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.